About Us  |  BVA-100  |  Investor Relations  |  Idant Division  |  Contact Us
 

About Us: Management

 
 

2/3/2010 - Presentation of Five Research Reports Involving Daxor's Blood Volume Analyzer at the 39th Annual Society of Critical Care Medicine Conference. Part 2: Direct Blood Volume Measurement Correlated With Improved Survival

  

1/22/2010 - 5 Major Research Reports from Studies Using Daxor's Blood Volume Analyzer Presented at the 39th Annual Society of Critical Care Medicine Conference. Part I: Studies on Leaky Capillary Syndrome

  

12/1/2009 - Daxor Announces that Medical University of South Carolina in Charleston Purchases Blood Volume Analyzer BVA-100

  
 

______________________

 
     
  2009 Second Quarter Earnings  
  June 2009 10-Q  
  2009 Proxy Statement  
  2008 Annual Report  
  2008 Form 10-K  
 

 

 
Executive Team

Joseph Feldschuh, M.D.

President and CEO

Stephen Feldschuh

Chief Operating Officer

David Frankel

Chief Financial Officer

Diane Meegan

Corporate Secretary

Deanna O'Brien

Vice President, Quality Systems and Regulatory Affairs

Everis Engstrom

Vice President, Engineering

Gary Fischman, Ph.D.

Vice President, Research and Development
   
Board of Directors  

Joseph Feldschuh, M.D.

Chairman of the Board

James A. Lombard

Director of the Company

Martin S. Wolpoff

Director of the Company

Robert Willens

Director of the Company

Bernhard Saxe

Director of the Company

Stanley Epstein, M.D.

Director of the Company

Mario Biaggi, Jr.

Director of the Company
   
Medical Advisory Board  

Philip Frost, M.D.

 

Robert L. Rosenthal, M.D.

 

Fred Gilbert, M.D.

 

James H. Brassel, M.D.

 
Menu Options

Daxor Home Page

Mission Statement

Privacy Statement

Company Management

Careers

Contact Us

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2009 Daxor Corporation. All Rights Reserved.